Today news
The same in other media
Biological E hopes to roll out Covid vaccine Corbevax by Nov-end
Reading now: 526
All about Biological E's Covid jab Biological E's anti-coronavirus shot, Corbevax, is a RBD protein sub-unit vaccine and is currently undergoing phase 2/3 clinical trials on adults.
The Phase 3 trials are going to be a study in comparison with the already licensed vaccines, though the study in children is not a comparative study, she further said. "We are submitting doses to Kasauli for release.
So it is my hope that at the day of launch… it is always been our vision to have close to ten crore doses on the day. By end of November this may happen as soon as we get the license," she said.
On the coronavirus vaccine manufacturing capacities, she said currently BE has the capacity to make one billion doses of Corbevax per annum, and 600
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
COVID-19
United States
|
Cases: 46 252 513
Deaths: 750 423
Recovered: 0
|
India
|
Cases: 34 321 025
Deaths: 459 652
Recovered: 0
|
Brazil
|
Cases: 21 835 785
Deaths: 608 235
Recovered: 0
|
United Kingdom
|
Cases: 9 215 683
Deaths: 141 607
Recovered: 0
|
Russia
|
Cases: 8 494 589
Deaths: 237 619
Recovered: 0
|